Search Results 151-160 of 9252 for 搜索引擎推荐咨询邮箱：lgooxc@hotmail.com
A Study of Patients Undergoing Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer to Evaluate Perioperative Circulating Tumor DNA as a Prognostic ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Contact the Evidence-Based Practice Research Program at Mayo Clinic about evidence synthesis, systematic reviews, practice guidelines & training ...
Mayo Clinic researcher Radhika Dhamija, M.B.B.S., is a neurologist and geneticist specializing in rare and undiagnosed diseases.
Once a request is submitted, the committee sends the indicated principal investigator an email confirming that the request was received and giving a timeline ...
Mayo Clinic researcher John M. Sheele, M.D., M.H.S., M.P.H., is an emergency medicine doctor who studies infectious diseases, global health and wilderness ...
Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...
About this study. The goals of this study are to identify biomarkers that allow improved staging or prognosis of the disease, and through the discovery of ...
The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different anticoagulants. Participation ...
Mayo Clinic researcher Ana L. Creo, M.D., is a pediatric endocrinologist researching diabetes and growth conditions.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.